Cresset Asset Management, LLC Bio N Tech Se Transaction History
Cresset Asset Management, LLC
- $17.3 Billion
- Q4 2024
A detailed history of Cresset Asset Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Cresset Asset Management, LLC holds 5,799 shares of BNTX stock, worth $694,894. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,799
Previous 6,331
8.4%
Holding current value
$694,894
Previous $751,000
12.12%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BNTX
# of Institutions
374Shares Held
40.2MCall Options Held
3.32MPut Options Held
2.26M-
Baillie Gifford & CO8.22MShares$985 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$528 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$515 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$227 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$217 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...